Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideaki Miyake

Showing results (1-10 of 587) with videos related to

Pageof 59
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association|January 4, 2022
New year's greetingsHideaki Miyake
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 16, 2019
[Ⅰ. Are There Any Changes in the Epidemiological Trends in Renal Cell Carcinoma in Japan ?]Hideaki Miyake
Annals of Translational Medicine|February 5, 2020
Cytoreductive nephrectomy following treatment with anti-vascular endothelial growth factor-targeted agents: is it surgically safe?Hideaki Miyake
International Journal of Urology : Official Journal of the Japanese Urological Association|January 26, 2023
New year's greetings 30-1Hideaki Miyake
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 3, 2012
[Significance of micrometastases in pelvic lymph nodes from patients with localized prostate cancer]Hideaki Miyake, Masato Fujisawa
International Journal of Urology : Official Journal of the Japanese Urological Association|December 16, 2011
Sigmoid neobladder as an ideal form of orthotopic urinary reconstructionHideaki Miyake, Masato Fujisawa
International Journal of Urology : Official Journal of the Japanese Urological Association|October 1, 2024
The role of cytoreductive nephrectomy in the era of immune checkpoint inhibitors: A review of current evidence and ongoing trialsTakuto Hara, Hideaki Miyake
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2013
[Resistance to tyrosine kinase inhibitors in renal cell carcinoma]Hideaki Miyake, Masato Fujisawa
Hinyokika Kiyo. Acta Urologica Japonica|December 21, 2012
[Adverse events associated with temsirolimus for patients with metastatic renal cell carcinoma]Hideaki Miyake, Masato Fujisawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 23, 2016
[Current status and future prospect of robot-assisted radical prostatectomy]Hideaki Miyake, Masato Fujisawa
Pageof 59

Showing results (1-10 of 587) with videos related to

Sort By:
Pageof 59
International Journal of Urology : Official Journal of the Japanese Urological Association|January 4, 2022
New year's greetingsHideaki Miyake
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 16, 2019
[Ⅰ. Are There Any Changes in the Epidemiological Trends in Renal Cell Carcinoma in Japan ?]Hideaki Miyake
Annals of Translational Medicine|February 5, 2020
Cytoreductive nephrectomy following treatment with anti-vascular endothelial growth factor-targeted agents: is it surgically safe?Hideaki Miyake
International Journal of Urology : Official Journal of the Japanese Urological Association|January 26, 2023
New year's greetings 30-1Hideaki Miyake
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 3, 2012
[Significance of micrometastases in pelvic lymph nodes from patients with localized prostate cancer]Hideaki Miyake, Masato Fujisawa
International Journal of Urology : Official Journal of the Japanese Urological Association|December 16, 2011
Sigmoid neobladder as an ideal form of orthotopic urinary reconstructionHideaki Miyake, Masato Fujisawa
International Journal of Urology : Official Journal of the Japanese Urological Association|October 1, 2024
The role of cytoreductive nephrectomy in the era of immune checkpoint inhibitors: A review of current evidence and ongoing trialsTakuto Hara, Hideaki Miyake
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2013
[Resistance to tyrosine kinase inhibitors in renal cell carcinoma]Hideaki Miyake, Masato Fujisawa
Hinyokika Kiyo. Acta Urologica Japonica|December 21, 2012
[Adverse events associated with temsirolimus for patients with metastatic renal cell carcinoma]Hideaki Miyake, Masato Fujisawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 23, 2016
[Current status and future prospect of robot-assisted radical prostatectomy]Hideaki Miyake, Masato Fujisawa
Pageof 59